Dr. Truong is the Chair and Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on several international head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and was a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
Boston University School of Medicine
BU-BMC Cancer Center
Boston Medical Center
VA Boston Healthcare System
2017-2021 Castle Connolly’s America’s Top Doctors:
2017-2021 Boston Magazine Top Doctors:
2013 Annals of Nuclear Medicine Vol 26. 2012:
Bronze Prize, Best Three Papers
2011 RSNA annual scientific meeting 2011:
Certificate of Merit
2010 National Cancer Institute, Physician Data Query (PDQ) Editorial Board :
National Institutes of Health Merit Award
2010 RSNA annual scientific meeting 2010:
2008 RSNA annual scientific meeting 2008:
Certificate of Merit
2003 Radiological Society of North America:
Roentgen Resident Research Award
03/01/2014 - 02/28/2021 (PI)
NRG Oncology Foundation, Inc. NIH-NCI
Cancer Survivorship Clinic Navigation Program
04/01/2017 - 04/30/2019 (PI)
Harvard Pilgrim Health Care (HPHC)
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 88 results.
Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2021 Mar; 52(1):229-236.View Related Profiles. PMID: 32152823
Qureshi MM, Oladeru OT, Lam CM, Dyer MA, Mak KS, Hirsch AE, Truong MT. Disparities in Laryngeal Cancer Treatment and Outcomes: An Analysis by Hospital Safety-Net Burden. Laryngoscope. 2021 06; 131(6):E1987-E1997.View Related Profiles. PMID: 33555062
Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). J Clin Oncol. 2021 Mar 20; 39(9):956-965. PMID: 33507809; PMCID: PMC8078254; DOI: 10.1200/JCO.20.03128;
Park JJ, Qureshi MM, Lam CM, Faden DL, Truong MT. A national cancer database analysis on stereotactic body radiation therapy of head and neck cancers. Am J Otolaryngol. 2021 May-Jun; 42(3):102913.View Related Profiles. PMID: 33460976
Wulu JA, Finlay SW, Truong MT, Ezzat WH. Immediate Postoperative Radiation Therapy after Free Tissue Transfer for Keloid Treatment. Laryngoscope. 2021 06; 131(6):E1818-E1820.View Related Profiles. PMID: 33399217
Margalit DN, Sacco AG, Cooper JS, Ridge JA, Bakst RL, Beadle BM, Beitler JJ, Chang SS, Chen AM, Galloway TJ, Koyfman SA, Mita C, Robbins JR, Tsai CJ, Truong MT, Yom SS, Siddiqui F. Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria. Head Neck. 2021 01; 43(1):367-391. PMID: 33098180; PMCID: PMC7756212; DOI: 10.1002/hed.26490;
Tsai CJ, Galloway TJ, Margalit DN, Bakst RL, Beadle BM, Beitler JJ, Chang S, Chen A, Cooper J, Koyfman SA, Ridge JA, Robbins J, Truong MT, Yom SS, Siddiqui F. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary. Head Neck. 2021 01; 43(1):392-406. PMID: 33068064
Fung CY, Vapiwala N, Mattes MD, Mohindra P, Shah C, Yechieli R, Truong MT, Sanders T, Arnone A, Royce TJ, Ennis RD. US Radiation Oncologists (Re)Defined: An American Society for Radiation Oncology Scope of Practice Study. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):335-343. PMID: 32956745; PMCID: PMC7500393; DOI: 10.1016/j.ijrobp.2020.09.029;
Moeller AR, Clancy PE, Qureshi MM, Guill JR, Dyer MA, Hirsch AE, Truong MT, Mak KS. Placard in Hand: A Simple, Inexpensive Intervention to Improve On-Treatment Visit Compliance in a Safety Net Radiation Oncology Patient Population. JCO Oncol Pract. 2020 11; 16(11):e1272-e1281.View Related Profiles. PMID: 32936711
Ito K, Takumi K, Meibom SK, Qureshi MM, Fujima N, Andreu-Arasa VC, Truong MT, Salama AR, Kaneda T, Sakai O. Risk assessment of osteoradionecrosis associated with periodontitis using 18F-FDG PET/CT. Eur J Radiol. 2020 Nov; 132:109259.View Related Profiles. PMID: 33012550; DOI: 10.1016/j.ejrad.2020.109259;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
Available to Mentor as: (Review Mentor Role Definitions)
Students interested in oncology, radiation oncology, head and neck cancer, skin cancer, brain tumors, quality of life and outcomes research.
Students interested in gaining exposure to novel technology for cancer therapy including Stereotactic Radiosurgery, Cyberknife Radiosurgery for brain tumors, recurrent head and neck cancer, metastatic disease.
Research / Scholarly Mentor
Work / Life Integration Mentor